1514
The procedure provides immediate results, and can be done in an outpatient or inpatient setting and under general or local anesthesia.
Patients typically can return home the same day without a catheter.
Provides rapid symptom relief and recovery with low complication rates.
It lifts and holds the enlarged prostate tissue out of the way so it no longer blocks the urethra.
It does not require ongoing medication, heating, cutting or removal of the prostate tissue.
Procedure takes less than one hour and does not preclude future.
The UroLift System is comprised of two main components:
The UroLift Delivery Device is inserted transurethrally through a rigid sheath under cystoscopic visualization to reach the targeted area of obstruction.
The obstructing prostatic lobes are held apart by small permanent UroLift Implants that are deployed by the delivery device.
Typically, four of such implants are placed into the prostate.
MRI can be used with the device.
The UroLift Implant is expected to produce a maximum temperature rise of 2.4°C after 15 minutes of continuous scanning.
Treatment with the UroLift System offers rapid and significant improvements in symptoms, urinary flow and quality of life sustained through five years.
Compared to medications, it has demonstrated a much more positive effect on quality of life for patients.
The treatment preserves sexual function and avoids complications typically associated with other BPH procedures.
It has the lowest catheter rate of the leading BPH procedures.
No additional sustained erectile or ejaculatory dysfunction.